期刊文献+

丙戊酸钠和苯妥英钠联合治疗对难治性癫痫患者痫样放电及认知功能的影响 被引量:23

Effect of sodium valproate combined with phenytoin sodium on the epileptiform discharge and cognitive function in patients with refractory epilepsy
下载PDF
导出
摘要 目的探讨丙戊酸钠和苯妥英钠联合治疗对难治性癫痫(RE)患者痫样放电及认知功能的影响。方法选择2011年2月至2015年2月新乡医学院第三附属医院收治的213例RE患者为研究对象,根据治疗方法将患者分为苯妥英钠组、丙戊酸钠组和联合治疗组,每组71例。苯妥英钠组患者给予苯妥英钠治疗,丙戊酸钠组患者给予丙戊酸钠治疗,联合治疗组患者给予丙戊酸钠和苯妥英钠联合治疗;3组患者分别于治疗前及治疗6个月后进行脑电图检测及认知功能评分,并评定治疗效果,对3组患者脑电图改善情况、认知功能评分及临床疗效进行比较。结果联合治疗组、苯妥英钠组和丙戊酸钠组患者治疗总有效率分别为80.28%(57/71)、60.56%(43/71)、59.15%(42/71),联合治疗组患者治疗总有效率显著高于苯妥英钠组和丙戊酸钠组(χ~2=8.412、9.596,P<0.05),但苯妥英钠组与丙戊酸钠组患者治疗总有效率比较差异无统计学意义(χ~2=0.003,P>0.05)。联合治疗组、苯妥英钠组和丙戊酸钠组患者脑电图总改善率分别为80.28%(57/71)、63.38%(45/71)、60.56%(43/71),联合治疗组患者脑电图总改善率显著高于苯妥英钠组和丙戊酸钠组(χ~2=7.520、8.412,P<0.05),但苯妥英钠组与丙戊酸钠组患者脑电图总改善率比较差异无统计学意义(χ~2=0.070,P>0.05)。治疗前3组患者总智商、语言智商、操作智商评分比较差异均无统计学意义(P>0.05),治疗后3组患者总智商、语言智商、操作智商评分均显著高于治疗前(P<0.05);治疗后,联合治疗组患者总智商、语言智商、操作智商评分均显著高于苯妥英钠组和丙戊酸钠组(P<0.05),但苯妥英钠组与丙戊酸钠组患者总智商、语言智商、操作智商评分比较差异均无统计学意义(P>0.05)。结论苯妥英钠和丙戊酸钠联合治疗可有效控制RE患者痫样放电,改善认知功能,提高治疗效果。 Objective To investigate the effect of sodium valproate combined with phenytoin sodium on the epileptiform discharge and cognitive function in patients with refractory epilepsy( RE). Methods A total of 213 patients with RE were selected from February 2011 to February 2015 in the Third Affiliated Hospital of Xinxiang Medical University. The patients were divided into phenytoin sodium group,sodium valproate group and combined treatment group according to the treatment methods,71 cases in each group. The patients in the phenytoin sodium group were treated with phenytoin sodium,the patients in the sodium valproate group were treated with sodium valproate,and the patients in the combined treatment group were treated with phenytoin sodium and sodium valproate. The electroencephalogram and cognitive function score of the patients in the three groups were performed before treatment and six months after treatment,and the therapeutic effect was evaluated. The improvement of electroencephalogram,cognitive function score and clinical effect were compared among the three groups. Results The total effective rate in the combined treatment group,phenytoin sodium group and sodium valproate group was 80. 28%( 57/71),60. 56%( 43/71) and 59. 15%( 42/71) respectively,the total effective rate in the combined treatment group was significantly higher than that in the phenytoin sodium group and sodium valproate group( χ~2= 8. 412,9. 596; P < 0. 05),but there was no significant difference in the total effective rate between phenytoin sodium group and sodium valproate group( χ~2=0. 003,P > 0. 05). The improvement rate of electroencephalogram in the combined treatment group,phenytoin sodium group and sodium valproate group was 80. 28%( 57/71),63. 38%( 45/71) and 60. 56%( 43/71) respectively,the improvement rate of electroencephalogram in the combined treatment group was significantly higher than that in the phenytoin sodium group and sodium valproate group( χ~2= 7. 520,8. 412; P < 0. 05),but there was no significant difference in the improvement rate of electroencephalogram between phenytoin sodium group and sodium valproate group( χ~2= 0. 070,P > 0. 05). There was no significant difference in the scores of total intelligence quotient,language intelligence quotient and performance intelligence quotient in the three groups before treatment( P > 0. 05). The scores of total intelligence quotient,language intelligence quotient and performance intelligence quotient after treatment were significantly higher than those before treatment in the three groups( P <0. 05). After treatment,the scores of total intelligence quotient,language intelligence quotient and performance intelligence quotient in the combined treatment group were significantly higher than those in the phenytoin sodium group and sodium valproate group( P > 0. 05); but there was no significant difference in the scores of total intelligence quotient,language intelligence quotient and performance intelligence quotient between the phenytoin sodium group and sodium valproate group( P > 0. 05).Conclusion Phenytoin sodium combined with sodium valproate can effectively control the epileptiform discharge,improve the cognitive function and improve the therapeutic effect in RE patients.
出处 《新乡医学院学报》 CAS 2018年第2期114-117,共4页 Journal of Xinxiang Medical University
关键词 难治性癫痫 丙戊酸钠 苯妥英钠 痫样放电 认知功能 refractory epilepsy sodium valproate phenytoin sodium epileptiform discharge cognitive function
  • 相关文献

参考文献10

二级参考文献128

  • 1朱秀丽,舒晓丹,丁晶,郭宁.老年癫痫患者脑电图检查与血清细胞因子水平及T淋巴细胞亚群的相关性[J].中国老年学杂志,2014,34(9):2372-2374. 被引量:23
  • 2张建梁,何敏贤,张宏启.迷走神经电刺激治疗癫痫的现状与展望[J].中国病理生理杂志,2005,21(11):2282-2285. 被引量:12
  • 3吴洵昳,洪震,吴逊,吴立文,赵忠新,王学峰,周东,吕传真.多中心双盲、随机、安慰剂对照评价左乙拉西坦添加治疗难治性部分性癫癎发作的疗效及安全性[J].中华神经科杂志,2007,40(3):149-153. 被引量:44
  • 4Aldenkamp AP, Arends J. Effects of epileptiform EEG discharges on cognitive function: is the concept of "transient cognitive impairment" still valid? Epilepsy Behav 2004:5 (Suppl 1 ):S25-34
  • 5Wang Q, Wang Z, Zhu P. Effects of predator stress on nitric oxide and neuronal nitric oxide synthase in rat hippocampus.Zhongguo Linchuang Kangfu (Chin J Clin Rehabil) 2003;7(22): 3048-9
  • 6Rakhilin SV, Olson PA, Nishi A, et al. A network of control mediated by regulator of calcium/calmodulin-dependent signaling.Science 2004;306(5696): 698-701
  • 7Wang YJ, Chen GH, Hu XY, et al. The expression of calcium/calmod-ulin-dependent protein kinase Ⅱ-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.Brain Res 2005;1031(1): 101-8
  • 8Tao-Cheng JH, Vinade L, Winters CA, et al. Inhibition of phosphatase activity facilitates the formation and maintenance of NMDA-induced cal-cium/calmodulin-dependent protein kinase Ⅱ clusters in hippocampal neurons.Neuroscience 2005;130(3): 651-6
  • 9Nguyen PV, Woo NH. Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog Neurobiol 2003;71(6): 401-37
  • 10Tremper-Wells B, Vallano ML. Nuclear calpain regulates Ca^2+-dependent signaling via proteolysis of nuclear Ca2+/calmodulin-dependent pro-tein kinase type Ⅳ in cultured neurons.J Biol Chem 2005;280(3): 2165-75

共引文献108

同被引文献354

引证文献23

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部